| Literature DB >> 35897878 |
Melania Siracusa1, Simone Bacchiocchi1, Alessandra Dubbini1, Debora Campacci1, Tamara Tavoloni1, Arianna Stramenga1, Martina Ciriaci1, Sonia Dall'Ara2, Arianna Piersanti1.
Abstract
Paralytic Shellfish Toxins (PSTs) are marine biotoxins, primarily produced by dinoflagellates of the genera Gymnodinium spp., Alexandrium spp. They can accumulate in shellfish and, through the food chain, be assimilated by humans, giving rise to Paralytic Shellfish Poisoning. The maximum permitted level for PSTs in bivalves is 800 μg STX·2HCl eqv/kg (Reg. EC N° 853/2004). Until recently, the reference analytical method was the Mouse Bioassay, but Reg. EU N° 1709/2021 entered into force on 13 October 2021 and identified in the Standard EN14526:2017 or in any other internationally recognized validated method not entailing the use of live animals as official methods. Then the official control laboratories had urgently to fulfill the new requests, face out the Mouse Bioassay and implement instrumental analytical methods. The "EURLMB SOP for the analysis of PSTs by pre-column HPLC-FLD according to OMA AOAC 2005.06" also introduced a simplified semiquantitative approach to discriminate samples above and below the regulatory limit. The aim of the present paper is to present a new presence/absence test with a cut-off at 600 μg STX·2HCl eqv/kg enabling the fast discrimination of samples with very low PSTs levels from those to be submitted to the full quantitative confirmatory EN14526:2017 method. The method was implemented, avoiding the use of a large number of certified reference standards and long quantification procedures, resulting in an efficient, economical screening instrument available for official control laboratories. The protocol was fully validated, obtaining good performances in terms of repeatability (<11%) and recovery (53-106%) and accredited according to ISO/IEC 17025. The method was applied to mollusks collected from March 2021 to February 2022 along the Marche region in the frame of marine toxins official control.Entities:
Keywords: HPLC-FLD; gastropods; marine biotoxins; official control; paralytic shellfish toxins; screening method
Mesh:
Substances:
Year: 2022 PMID: 35897878 PMCID: PMC9331220 DOI: 10.3390/molecules27154702
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Figure 1Chemical structures of the PST toxins identified and reported in literature. PSTs are produced by marine microalgae, specifically dinoflagellates of the genera.
Validation study results on mussels and gastropods. Application of Single factor ANOVA (only mussel).
| TOXIN | N | RSDr | R | N | RSDr 1 | RSDR | R | n | t | t × RSDr% | ML | STC Worst Case | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| % | % | (µg STX·2HCl eqv/kg) | ||||||||||||
| Gastropods | Mussels | |||||||||||||
| Spiked | N days | 1 | 5 | |||||||||||
|
| 200 | 5 | 17 | 62 | 25 | 5.1 | 25 | 75 | 20 | 2528 | 19,285 |
|
| |
|
| 140 | 5 | 20 | 72 | 25 | 6.4 | 33 | 80 | ||||||
|
| 100 | 5 | 8.1 | 56 | 25 | 4.2 | 28 | 67 | ||||||
|
| 120 | 5 | 12 | 106 | 25 | 8.0 | 50 | 79 | ||||||
|
| 100 | 5 | 8.3 | 53 | 25 | 11 | 23 | 69 | ||||||
|
| 160 | 5 | 20 | 88 | 25 | 11 | 35 | 71 | ||||||
|
| 160 | 5 | 18 | 60 | 25 | 7.9 | 32 | 72 | ||||||
|
|
|
|
|
|
| |||||||||
RSDr% = repeatability relative standard deviation, R% = recovery, RSDR% = reproducibility relative standard deviation, n = number of replicate, t = t of student, STC = screening target concentration.
PSTs screening method proficiency tests (PTs) results.
|
|
|
|
|
| |
|---|---|---|---|---|---|
|
| |||||
|
|
| PSTs to be confirmed | >800 | ||
|
| <600 | <800 | |||
|
| <600 | <800 | |||
|
|
| PSTs to be confirmed | 2271 | 1780 | 2.1 |
|
| PSTs to be confirmed | 3075 | 2222 | 2.9 | |
|
| PSTs to be confirmed | 4272 | 2771 | 3.9 | |
|
|
| PSTs to be confirmed | 1803 | 1280 | |
|
| PSTs to be confirmed | 1029 | 719 | ||
|
| PSTs to be confirmed | 952 | 608 | ||
|
| PSTs to be confirmed | 1204 | 633 | ||
|
| PSTs to be confirmed | 810 | 692 | ||
|
| PSTs to be confirmed | 608 | 577 | ||
|
| PSTs to be confirmed | 695 | 865 | ||
|
| PSTs to be confirmed | 870 | 853 | ||
|
| PSTs to be confirmed | 706 | 706 | ||
|
| PSTs to be confirmed | 244 | 342 | ||
|
|
| PSTs to be confirmed | >800 | ||
|
| PSTs to be confirmed | <800 | |||
|
| <600 | <800 | |||
HPLC-FLD conditions for PSTs analysis.
|
| Column | Supelcosil LC-18, 15 cm × 4.6 mm (i.d.), 5 µm (SUPELCO) | ||
| Mobile phase A | 0.1 M ammonium formate, pH 6.0 | |||
| Mobile phase B | 0.1 M ammonium formate, pH 6.0 with 5% ( | |||
| Flow rate | 1.0 mL/min | |||
| Injection volume | 100 µL | |||
| Injector temperature | ±6 °C | |||
| Column temperature | ±35 °C | |||
| Gradient | Time (min) | A (%) | B (%) | |
| 0 | 100 | 0 | ||
| 5 | 95 | 5 | ||
| 9 | 30 | 70 | ||
| 11 | 100 | 0 | ||
| 15 | 100 | 0 | ||
|
| Wavelength | Excitation | 340 nm | |
| Emission | 395 nm | |||
| Run time | 15 min | |||
Calculation of single toxin contribution to the cut-off (600 µg STX·2HCl eqv/kg) for the presence/absence screening method.
| Coelution Group | Toxin | TEF [ | Group | TEF | Single toxin | Group | Group | Modulated 1
| Recalculated Group | |
|---|---|---|---|---|---|---|---|---|---|---|
|
| 1 |
|
|
|
| 43 | 172 | 172 |
| 200 |
| 2 |
|
| 43 | |||||||
| 3 | dc GTX2 | 0.2 | 43 | |||||||
| 4 | dc GTX3 | 0.4 | 43 | |||||||
|
| 5 |
|
|
|
| 43 | 86 | 143 |
| 60 |
| 6 |
|
| 43 | |||||||
|
| 7 |
|
|
|
| 43 | 43 | 430 |
| 16 |
|
| 8 | GTX6 | 0.1 |
|
| 43 | 129 | 129 |
| 120 |
| 9 | NEO | 1 | 43 | |||||||
| 10 |
|
| 43 | |||||||
|
| 11 |
|
|
|
| 43 | 43 | 108 |
| 40 |
|
| 12 |
|
|
|
| 43 | 43 | 43 |
| 160 |
|
| 13 |
|
|
|
| 43 | 86 | 860 |
| 14 |
| 14 |
|
| 43 | |||||||
|
|
|
|
| |||||||
1 The concentration of the reference toxin of the group was redefined as a result of the instrumental response.
Figure 2Flow diagram for PSTs screening results interpretation.